CS logo
small CS logo
Midcentral District Health Board

Palmerston North, New Zealand
Hospital in Palmerston North
50 Ruahine Street, Roslyn, Palmerston North 4442
354 Beds

About Midcentral District Health Board


Palmerston North Hospital is the main public hospital in Palmerston North, New Zealand. The hospital is located at the northern end of Ruahine Street, 2 km northeast of The Square.
There are 354 beds in Midcentral District Health Board.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Midcentral District Health Board


During the past decade, Midcentral District Health Board conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Midcentral District Health Board" #1 collaborator was "AbbVie" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

Clinical Trials Conditions at Midcentral District Health Board


According to Clinical.Site data, the most researched conditions in "Midcentral District Health Board" are "Lymphocytic Leukemia, Chronic" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Midcentral District Health Board" in a lesser frequency.

Clinical Trials Intervention Types at Midcentral District Health Board


Most popular intervention types in "Midcentral District Health Board" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (1 trials), "Chlorambucil" (1 trials), "Magrolimab" (1 trials), "Obinutuzumab" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Midcentral District Health Board


The vast majority of trials in "Midcentral District Health Board" are 2 trials for "All" genders.

Clinical Trials Status at Midcentral District Health Board


Currently, there are NaN active trials in "Midcentral District Health Board". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Midcentral District Health Board, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Midcentral District Health Board, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Departments of Midcentral District Health Board


Midcentral District Health Board has several departments that took part in Clinical trials: "Palmerston North Hospital; Regional Cancer Treatment Service" - 4 trials